Clinical Research Clinical Trial and Pharmacogenomics
CombiMatrix announced that the DoD has awarded a one-year, $2.2 mln contract to CombiMatrix for further development of its microarray technologies for a multipathogen- and chemical-detection system.
Filed under: DNA, DNA diagnostics, DNA therapeutics, microarray, microarray blog | Leave a Comment »
Imagine a diabetic patient from NewYork being put on a drug regimen distinct from a patient London. Personalized medicine allows tratement to decided on the genetic make up of the individual. Genetically europeans and asians and others have different ways of responding to same treatment genetically FortunatelyIf Indian researchers have their way, such customised medication [...]
Filed under: clinical diagnostics, DNA database, DNA diagnostics, DNA therapeutics, gene expression, gene therapy, genetic medicine, genetics, genotyping, microarray blog, personalized medicine, Pharmacogenomics | 6 Comments »
The complete list is published at forbes website Breast Cancer Adult-Onset Diabetes Obesity Drug Metabolism Crohn’s Disease Prostate Cancer Duchenne Muscular Dystrophy Rett Syndrome Macular Degeneration Alzheimer’s Disease Heart Attack Gene Testing: Related Blogs eyeondna , gensherpa , OmicsOmics
Filed under: clinical diagnostics, diagnostic microarray, DNA diagnostics, DNA medicine, DNA therapeutics, gene expression, genetics, Genomics, microarray, microarray for clinical diagnostics, personalized medicine, Pharmacogenomics | 1 Comment »
During 10th Annual Meeting of the American Society of Gene Therapy (ASGT) in Seattle a new methid for Regulating Expression of therapeutic Genes was introduced. For many applications, gene transfer is being employed to engineer cells for therapeutic applications, chek the following links for article 1 IFR , 2 (Nature), 3 (NIH) , that require [...]
Filed under: bioinformatics blog, DNA, DNA medicine, DNA network, DNA news, DNA therapeutics, gene expression, gene therapy, genetic medicine, genetics, personalized medicine, Pharmacogenomics, transgenomics | 1 Comment »
AGI Dermatics a biotechnology company specializing in DNA skin repair and photobiology claims to be working on a DNA damage-control product thus far is called Dimericine Currently in stage-three clinical trials. Dimericine, the company claims to contain, a customized enzyme that can recognize DNA damage caused by ultraviolet light and speed up repair “We call it a morning-after lotion. It can be used after [...]
Filed under: bioinformatics blog, DNA medicine, DNA therapeutics, genetics, Genomics, microarray blog | 3 Comments »
